Gene · 9507
Papers2,479
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
421 to 440 of 2,479
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Extra Cellular Matrix Remodeling: An Adjunctive Target for Spinal Cord Injury and Intervertebral Disc Degeneration. | Neurospine | 2022 | 36203290 | PubTator, text mining | PubMed |
| The role of extracellular vesicles in osteoarthritis treatment via microenvironment regulation. | Biomater Res | 2022 | 36199125 | PubTator, text mining | PubMed |
| Parvalbumin interneuron-derived tissue-type plasminogen activator shapes perineuronal net structure. | BMC Biol | 2022 | 36199089 | PubTator, text mining | PubMed |
| The Potential Role of Cytokines in Diabetic Intervertebral Disc Degeneration. | Aging Dis | 2022 | 36186138 | PubTator, text mining | PubMed |
| Inhibition of HIPK2 protects stress-induced pathological cardiac remodeling. | EBioMedicine | 2022 | 36182775 | PubTator, text mining | PubMed |
| Aortic Cellular Diversity and Quantitative Genome-Wide Association Study Trait Prioritization Through Single-Nuclear RNA Sequencing of the Aneurysmal Human Aorta. | Arterioscler Thromb Vasc Biol | 2022 | 36172868 | PubTator, text mining | PubMed |
| LCK-Mediated RIPK3 Activation Controls Double-Positive Thymocyte Proliferation and Restrains Thymic Lymphoma by Regulating the PP2A-ERK Axis. | Adv Sci (Weinh) | 2022 | 36161785 | PubTator, text mining | PubMed |
Knockdown of triggering receptor expressed on myeloid cells 1 (TREM1) inhibits endoplasmic reticulum stress and reduces extracellular matrix degradation and the apoptosis of human nucleus pulposus cells. | Exp Ther Med | 2022 | 36160910 | PubTator, text mining | PubMed |
| Clinical relevance of biomarkers, new therapeutic approaches, and role of post-translational modifications in the pathogenesis of Alzheimer's disease. | Front Aging Neurosci | 2022 | 36158539 | PubTator, text mining | PubMed |
| Sappanone A Alleviated IL-1β-Induced Inflammation in OA Chondrocytes through Modulating the NF-κB and Nrf2/HO-1 Pathways. | Dis Markers | 2022 | 36157214 | PubTator, text mining | PubMed |
| Differential Expression and Localization of ADAMTS Proteinases in Proliferative Diabetic Retinopathy. | Molecules | 2022 | 36144730 | PubTator, text mining | PubMed |
| Estrogen Receptor Subtypes Elicit a Distinct Gene Expression Profile of Endothelial-Derived Factors Implicated in Atherosclerotic Plaque Vulnerability. | Int J Mol Sci | 2022 | 36142876 | PubTator, text mining | PubMed |
| Mining High-Level Imaging Genetic Associations via Clustering AD Candidate Variants with Similar Brain Association Patterns. | Genes (Basel) | 2022 | 36140686 | PubTator, text mining | PubMed |
| Natural Compounds Affecting Inflammatory Pathways of Osteoarthritis. | Antioxidants (Basel) | 2022 | 36139796 | PubTator, text mining | PubMed |
| Inhibition of KRAS, MEK and PI3K Demonstrate Synergistic Anti-Tumor Effects in Pancreatic Ductal Adenocarcinoma Cell Lines. | Cancers (Basel) | 2022 | 36139627 | PubTator, text mining | PubMed |
| Identification Markers of Carotid Vulnerable Plaques: An Update. | Biomolecules | 2022 | 36139031 | PubTator, text mining | PubMed |
| Proteolytic modulation of tumor microenvironment signals during cancer progression. | Front Oncol | 2022 | 36132127 | PubTator, text mining | PubMed |
| The Wnt signaling cascade in the pathogenesis of osteoarthritis and related promising treatment strategies. | Front Physiol | 2022 | 36117702 | PubTator, text mining | PubMed |
| A review of brain imaging biomarker genomics in Alzheimer's disease: implementation and perspectives. | Transl Neurodegener | 2022 | 36109823 | PubTator, text mining | PubMed |
| PARP3 supervises G9a-mediated repression of adhesion and hypoxia-responsive genes in glioblastoma cells. | Sci Rep | 2022 | 36109561 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9507/papers?page=22